There are currently 67 active clinical trials seeking participants for Type 1 Diabetes research studies. The states with the highest number of trials for Type 1 Diabetes participants are California, Texas, Florida and Colorado.
Commercial or Open Source Closed Loop Impact on Pregnancy Study
NCT06654713
Recruiting
The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study aims to answer are: * What are the maternal and neonatal outcomes with AID system use in pregnancy? * What are the glycemic outcomes with AID system use in pregnancy? * What are the behavioral and emotional outcomes with AID system use in pregnancy? Researchers will compare pregnant people who use c... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
05/06/2025
Locations: University of California, San Francisco, San Francisco, California
Conditions: Type 1 Diabetes, Pregnancy, High Risk, Insulin Dependent Diabetes, Pregnancy Related
Register for Updates
BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes
NCT05488119
Recruiting
Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) improve representation of youth in the literature, (2) address the gap in knowledge of barriers and promoters in youth, and (3) identify and address factors associated with diabetes technology uptake and utilization.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
04/22/2025
Locations: Stanford University, Stanford, California
Conditions: Type 1 Diabetes
Register for Updates
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
NCT05653518
Recruiting
This study will examine the potential cardiovascular effect(s) of artificial pancreas (AP) technology in patients with type 1 diabetes. AP technology is a system of devices that closely mimics the glucose-regulating function of a healthy human pancreas. It includes an insulin pump and a continuous glucose monitor (CGM). In this study, the investigators will research whether improvements in blood glucose levels and blood glucose variability will in turn decrease biomarkers of inflammation and end... Read More
Gender:
ALL
Ages:
Between 18 years and 40 years
Trial Updated:
04/17/2025
Locations: University of Virginia Health System, Charlottesville, Virginia
Conditions: Type 1 Diabetes
Register for Updates
FAM (Follower, Action Plan, and Remote Monitoring) Intervention to Reduce Severe Hyperglycemia in Adults With Type 1 Diabetes Mellitus at Risk for Diabetic Ketoacidosis
NCT06114186
Recruiting
Diabetic ketoacidosis (DKA) results in significant morbidity and healthcare utilization and is the main contributor to loss of life expectancy in people with diabetes mellitus type 1 (T1DM) \<50 years old. This suggests the need to develop interventions to reduce DKA events. Innovative features of newer continuous glucose monitoring devices offer opportunities for novel strategies to reduce DKA. Designating a family member, friend, or caregiver as a Follower was associated with reduction in HbA1... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/16/2025
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Type 1 Diabetes
Register for Updates
Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)
NCT06908057
Recruiting
The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.
Gender:
ALL
Ages:
2 years and above
Trial Updated:
04/02/2025
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Type 1 Diabetes, Celiac Disease
Register for Updates
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
NCT05594563
Recruiting
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insulin? * Does it preserve what is left of the body's insulin production? Participants will take either DFMO or a placebo (looks like DFMO but has no active ingredients) two times a day for about 6 months. Participants will have 6 in person visits and 1 phone visit over a period of 12 months. Visits wi... Read More
Gender:
ALL
Ages:
Between 4 years and 40 years
Trial Updated:
03/28/2025
Locations: Barbara Davis Center, Aurora, Colorado +5 locations
Conditions: Type 1 Diabetes
Register for Updates
Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart)
NCT05992350
Recruiting
The goal of this observational study is to test the Garmin Vivosmart in children and youth (8-21) with Type 1 Diabetes (T1D) and their parents. The main questions it aims to answer are: * Does the Garmin Vivosmart increase physical activity (PA)? * Does the Garmin Vivosmart improve T1D status Participants will: * Wear the Garmin Vivosmart (4 or higher) for a year * Complete surveys at the beginning, middle and end of participation asking about your T1D, T1D management, and PA * Parents of chi... Read More
Gender:
ALL
Ages:
Between 8 years and 21 years
Trial Updated:
03/27/2025
Locations: Children's Mercy, Kansas City, Missouri
Conditions: Type 1 Diabetes
Register for Updates
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
NCT06014879
Recruiting
The EMPoWER Study randomized clinical trial is a strengths-based behavioral intervention delivered to youth with type 1 diabetes (age 10 to 13) and their parents. The purpose of the intervention is to improve glycemic, behavioral, and psychosocial outcomes in youth with diabetes using a multiple systems approach that engages youth, their parents, and diabetes care providers to identify and build youths' diabetes strengths. The primary aim of this study is to assess the intervention impact on gly... Read More
Gender:
ALL
Ages:
Between 10 years and 99 years
Trial Updated:
03/26/2025
Locations: Baylor College of Medicine, Houston, Texas
Conditions: Type 1 Diabetes
Register for Updates
InvesT1D: Promoting Adolescent Investment in Diabetes Care
NCT06384911
Recruiting
The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
03/25/2025
Locations: Seattle Children's, Seattle, Washington
Conditions: Type 1 Diabetes
Register for Updates
R-5280 in Newly Diagnosed Patients with Type 1 Diabetes
NCT06057454
Recruiting
Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients
Gender:
ALL
Ages:
Between 11 years and 17 years
Trial Updated:
03/19/2025
Locations: Edward Jenner Research Group LLC, Plantation, Florida +2 locations
Conditions: Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes Mellitus, Type 1
Register for Updates
The ILet Experience Study
NCT06891898
Recruiting
A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.
Gender:
ALL
Ages:
6 years and above
Trial Updated:
03/18/2025
Locations: Beta Bionics, Irvine, California
Conditions: Type 1 Diabetes
Register for Updates
IHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults with Type 1 Diabetes
NCT06348160
Recruiting
This research study aims to test a financial and health insurance iHERO Toolkit for young adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want to understand the impact of the iHERO Toolkit on diabetes self-management, financial stress, and health insurance literacy outcomes. The investigators are doing this study because it will help to better understand how to suppor... Read More
Gender:
ALL
Ages:
Between 18 years and 30 years
Trial Updated:
03/14/2025
Locations: Children's Hospital Los Angeles, Los Angeles, California +3 locations
Conditions: Type 1 Diabetes
Register for Updates